| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/06/2011 | EP2340247A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 07/06/2011 | EP2340245A2 A novel betaine cocrystal of epalrestat |
| 07/06/2011 | EP2340244A1 Compounds and methods of use |
| 07/06/2011 | EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 07/06/2011 | EP2340242A2 Compounds for treating ophthalmic diseases and disorders |
| 07/06/2011 | EP2340241A1 Organic compounds for applications in bacterial infections treatment |
| 07/06/2011 | EP2340043A1 Topical composition comprising a combination of at least two penetration enhancing agents |
| 07/06/2011 | EP2340042A2 Methods and compositions for the treatment of cancer |
| 07/06/2011 | EP2340041A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents |
| 07/06/2011 | EP2340040A2 Modulation of axon degeneration |
| 07/06/2011 | EP2340033A1 Preparation comprising insulin, nicotinamide and an amino acid |
| 07/06/2011 | EP2340027A2 Methods and compositions for the treatment of cancer |
| 07/06/2011 | EP2340025A1 Cgrp receptor antagonists |
| 07/06/2011 | EP2340024A1 Use of 3,11b-cis-dihydrobenazine in the treatment of dementia and associated cognitive deficit |
| 07/06/2011 | EP2340023A1 The trpvl antagonist sb-705498 for treating rhinitis |
| 07/06/2011 | EP2340022A1 Combination therapy for tuberculosis |
| 07/06/2011 | EP2340021A1 Substituted pyrrolidine-2-carboxamides |
| 07/06/2011 | EP2340020A1 Manganese and cobalt complexes, their preparation and use |
| 07/06/2011 | EP2340017A2 Treatment of adrenal insufficiency |
| 07/06/2011 | EP2340016A2 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
| 07/06/2011 | EP2340014A1 Eye drop with difluprednate for macular edema treatment |
| 07/06/2011 | EP2339919A1 Bicyclic dihydroimidazolone cgrp receptor antagonists |
| 07/06/2011 | EP2152370B1 Aryl ether pyridazinone derivatives |
| 07/06/2011 | EP2077996B1 Purification process of montelukast and its amine salts |
| 07/06/2011 | EP2066663B1 Heterocyclic fxr binding compounds |
| 07/06/2011 | EP2010519B1 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 07/06/2011 | EP1940396B1 Anthelmintic formulations |
| 07/06/2011 | EP1877050B1 Substituted beta-lactams and their use in medicine |
| 07/06/2011 | EP1853576B1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 07/06/2011 | EP1802373B1 Carboxy-amido-triazoles for the localized teatment of ocular diseases |
| 07/06/2011 | EP1696897B1 Compositions for treating diabetes |
| 07/06/2011 | EP1692101B1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| 07/06/2011 | EP1643984B1 Use of parthenolide derivatives as antileukemic and cytotoxic agents |
| 07/06/2011 | EP1587834B1 Uses of il-23 mammalian cytokine; related reagents |
| 07/06/2011 | EP1493734B1 Novel crystal form of 5-hydroxy-1-methylhydantoin |
| 07/06/2011 | EP1492765B1 Novel gamma secretase inhibitors |
| 07/06/2011 | EP1455899B1 Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne |
| 07/06/2011 | EP1434588B1 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain |
| 07/06/2011 | EP1165049B2 Agglomerates by crystallisation |
| 07/06/2011 | EP1064000B1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders |
| 07/06/2011 | EP0998291B2 Treatment of diabetes with thiazolidinedione and sulphonylurea |
| 07/06/2011 | EP0707478B1 Improved nicotine lozenge |
| 07/06/2011 | CN1997638B 1,1'-(1,2-ethynediyl)bis-benzene derivatives as PTP1-B inhibitors |
| 07/06/2011 | CN1993338B Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| 07/06/2011 | CN1988899B The euphorbia lunulate bge extractant and production method and use thereof |
| 07/06/2011 | CN1965825B Ocular surface applied medicament for treating eyes immunological disease and inhibiting proliferation and neovascularization |
| 07/06/2011 | CN1953982B 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 07/06/2011 | CN1939540B Medicine composition containing insulin sensibilizer and B-family vatamines |
| 07/06/2011 | CN1903220B Health-care food with function of improving skeletal density and its prepn. method |
| 07/06/2011 | CN1893944B 3-cyano-quinoline derivatives with antiproliferative activity |
| 07/06/2011 | CN1882593B Fused pentacyclic polyethers |
| 07/06/2011 | CN1882541B derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 07/06/2011 | CN1867554B Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors |
| 07/06/2011 | CN1867549B Cyclopropyl derivatives as NK3 receptor antagonists |
| 07/06/2011 | CN1777577B Antibacterial agents |
| 07/06/2011 | CN102119217A Novel lipid formulations for nucleic acid delivery |
| 07/06/2011 | CN102119163A Diazacarbazoles and methods of use |
| 07/06/2011 | CN102119162A Diazacarbazoles and methods of use |
| 07/06/2011 | CN102119161A Sulfur-containing heterocyclic derivative having ss-secretase-inhibiting activity |
| 07/06/2011 | CN102119160A Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 07/06/2011 | CN102119157A Tricyclic 2,4-diamino-L,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders |
| 07/06/2011 | CN102119156A Substituted pyrroles and methods of use |
| 07/06/2011 | CN102119152A Organic compounds |
| 07/06/2011 | CN102119142A Salicylamide derivatives as nicotinic alpha 7 modulators |
| 07/06/2011 | CN102119141A Novel polymorphic forms of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 07/06/2011 | CN102119140A Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof |
| 07/06/2011 | CN102119138A Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 07/06/2011 | CN102119047A Heteroaryl derivatives as DGAT1 inhibitors |
| 07/06/2011 | CN102119034A Tablet quickly disintegrating in the oral cavity and method for producing the same |
| 07/06/2011 | CN102119030A Antihistamine and antihistamine-like nasal application, products, and method |
| 07/06/2011 | CN102119029A 1,5-diphenyl-pyrrolidin-2-one compounds as CB-1 ligands |
| 07/06/2011 | CN102119028A Amino alcohol derivatives for the treatment of demyelinating peripheral neuropathies |
| 07/06/2011 | CN102119025A Improved formulations for poorly permeable active pharmaceutical ingredients |
| 07/06/2011 | CN102119024A A solid pharmaceutical formulation |
| 07/06/2011 | CN102119023A Unit dosage of apadenoson |
| 07/06/2011 | CN102119021A Progestin-containing drug delivery system |
| 07/06/2011 | CN102118981A Plant extract and PUFA combinations |
| 07/06/2011 | CN102118976A Nutritional composition for infants delivered via caesarean section |
| 07/06/2011 | CN102118973A Povidone iodine, a novel alternative preservative for ophthalmic compositions |
| 07/06/2011 | CN102118972A Novel modulators of sphingosine phosphate receptors |
| 07/06/2011 | CN102118970A Pharmaceutical formulations containing dopamine receptor ligands |
| 07/06/2011 | CN102115485A Prodrug based on cytosine arabinoside structure, and synthesis method and application thereof |
| 07/06/2011 | CN102115484A Amphotericin B degraded product, preparation method and application thereof |
| 07/06/2011 | CN102115483A Halogenated dideoxy sugar derivative, preparation method and application thereof |
| 07/06/2011 | CN102115482A Annatto oligosaccharide, preparation method and usage thereof |
| 07/06/2011 | CN102115478A Furo-indole compounds and preparation method and application thereof |
| 07/06/2011 | CN102115473A Bis-heterocyclic imidazolyl compounds |
| 07/06/2011 | CN102115472A 3-(2-pyrromethene)azaindoline-2-one derivatives and preparation method and application thereof |
| 07/06/2011 | CN102115470A Pyrimidine small-molecular compounds, and preparation method and application thereof |
| 07/06/2011 | CN102115467A Method for preparing catechin monomers |
| 07/06/2011 | CN102115460A Geldanamycin derivative and preparation method and application thereof |
| 07/06/2011 | CN102115429A (E)-1-(3,5-dimethoxyphenyl)-2-(3,5-dihydroxy-4-methoxyphenyl)ethylene, and preparation method and application thereof |
| 07/06/2011 | CN102114400A Method for preparing sodium alginate-iron chlorophyllin sodium microcapsule |
| 07/06/2011 | CN102114248A Poly (2-hydroxyl-3-(2-hydroxyethylamino) propyl methacrylate) (PGEA)-isoplyacid nano compound antitumor medicament and preparation method thereof |
| 07/06/2011 | CN102114245A Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof |
| 07/06/2011 | CN102114244A Compositions and methods for treating cognitive disorders |
| 07/06/2011 | CN102114238A Ointment for treating herpes zoster and preparation method thereof |
| 07/06/2011 | CN102114235A External Chinese herbal preparation for treating woman lobular hyperplasia of mammary glands and preparation method thereof |
| 07/06/2011 | CN102114220A Quality control method for Chinese medicinal preparation for treating traumatic injuries and rheumatoid sacrodynia |
| 07/06/2011 | CN102114219A External ointment for dispersing swelling, relieving pain and diminishing inflammation |